10
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60026 |
KIF18A-IN-2
|
Microtubule Associated | Cytoskeletal Signaling |
KIF18A-IN-2 是有丝分裂驱动蛋白 Kif18A 的抑制剂,IC50 为 28 nM,可用于染色体不稳定性相关漏洞的研究。 | |||
T70058 |
PQR514
|
||
PQR514 is a potent pan-PI3K inhibitor (Ki 110alpha =2.2 nM). PQR514 is a follow-up compound for the phase-II clinical compound PQR309. PQR514 has an improved potency both in vitro and in cellular assays with respect to its predecessor compounds. It shows superiority in the suppression of cancer cell proliferation and demonstrates significant antitumor activity in an OVCAR-3 xenograft model at concentrations approximately eight times lower than PQR309 | |||
T63112 | VEGFR-IN-3 | ||
VEGFR-IN-3 (compound 3f) 是 VEGFR 抑制剂。VEGFR-IN-3 抑制 OVCAR-4 和 MDA-MB-468 癌细胞的生长,其 IC50值分别为 0.29 和 0.35 μM。VEGFR-IN-3 可用于癌症的研究。 | |||
T63383 | SZ-015268 | ||
SZ-015268 是 CDK7 抑制剂 (IC50: 23.56 nM),对HCC70 (IC50: 33 nM)、OVCAR-3 (IC50: 80.56 nM)、HCT116 (IC50: 12.53 nM) 和 HCC1806 (IC50: 61.55nM) 细胞增殖具有抑制作用。SZ-015268 表现出极显着的抗肿瘤作用。 | |||
T82516 |
E(c(RGDfK))₂
|
||
E(c(RGDfK))是一种针对αvβ3整联蛋白的特异性结合片段,表现出对肿瘤的靶向作用。在人卵巢癌OVCAR-3异种移植肿瘤模型中,该化合物的摄取有所提升,适用于癌症研究领域。 | |||
T36449 |
(S)-α-Methylbenzyl Ricinoleamide
|
||
(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM. | |||
T63110 |
CBP/p300-IN-15
|
||
CBP/p300-IN-15 (compound 13a) 是一种有效的 p300 (IC50: 2.5 nM) 和 CBP (IC50: 28.0 nM) 抑制剂。CBP/p300-IN-15 能够较好的抑制 OVCAR-3 细胞 (EC50: 0.865 μM) 和 A2780 细胞 (EC50: 2.71 μM)。 CBP/p300-IN-15 能够用于研究卵巢癌。 | |||
T33699 |
NLCQ-1 HCl
NLCQ1,NLCQ-1, NLCQ 1,NSC 709257 |
||
NLCQ-1 is a novel weak DNA-intercalative bioreductive compound. NLCQ-1 exhibited a C50 of 44 microM. NLCQ-1 demonstrated significant hypoxic selectivity in several rodent (V79, EMT6, SCCVII) or human (A549, OVCAR-3) tumor cell lines. Its potency as a hypo | |||
T41070 |
LP-184
|
||
LP-184 (Compound 6), referred to as an acylfulvene analog, demonstrates the ability to inhibit tumor growth with noteworthy anti-cancer efficacy observed across multiple cell lines, including ovarian, colon, prostate, and pancreatic. | |||
T10106 | 3-arylisoquinolinamine derivative | Others | Others |
3-arylisoquinolinamine derivative is a compound with antitumor activity. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1477 | Ceanothic acid | Others | Others |
Ceanothic acid derivatives show cytotoxic effect against OVCAR-3 and HeLa cancer cell lines. | |||
TN2529 |
1-Decarboxy-3-oxo-ceanothic acid
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
1-Decarboxy-3-oxo-ceanothic acid shows in vitro cytotoxic activity in a human ovarian adenocarcinoma cell line, the cytotoxic effect is mediated, at least in part, by the induction of apoptosis. It shows cytotoxic against OVCAR-3 and HeLa cancer cell line | |||
T83558 | (3S,4aS,10aS)-3-(Acetyloxy)-2,3,4,4a,10,10a-hexahydro-6-hydroxy-1,1,4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone | ||
(3S,4aS,10aS)-3-(Acetyloxy)-2,3,4,4a,10,10a-hexahydro-6-hydroxy-1,1,4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone(化合物3)是从丹参(Salvia miltiorrhiza)根提取的棕榈酸盐。该化合物展现出抗癌活性,对于不同的人类癌症细胞系具有显著的抑制效果,其DC50值分别为:HeLa细胞系25.5 μg/mL、HepG2细胞系37.5 μg/mL以及OVCAR-3细胞系30.2 μg/mL。 | |||
T35409 |
(+)-δ-Cadinene
|
Apoptosis; Antibacterial | Apoptosis; Microbiology/Virology |
(+)-δ-Cadinene 是一种从G. hirsutum 中发现的倍半萜,具有抗菌、杀虫、抗癌和抗增殖活性。 它对肺炎双球菌的MIC 值为31.25 μg/ml,对 A. stephensi、A. aegypti 和 C. quinquefasciatust 三龄幼虫的LC50s 值分别8.23、9. 2和3。(+)-δ-Cadinene(10、50 和 100 μM)可诱导 OVCAR-3 人类卵巢癌细胞凋亡并抑制其增殖。 |